The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices (original) (raw)

625

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appella E., Weber I. T., Blasi F. Structure and function of epidermal growth factor-like regions in proteins. FEBS Lett. 1988 Apr 11;231(1):1–4. doi: 10.1016/0014-5793(88)80690-2. [DOI] [PubMed] [Google Scholar]
  2. BLOODWORTH J. M., Jr Diabetic retinopathy. Diabetes. 1962 Jan-Feb;11:1–22. [PubMed] [Google Scholar]
  3. Bashkin P., Doctrow S., Klagsbrun M., Svahn C. M., Folkman J., Vlodavsky I. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry. 1989 Feb 21;28(4):1737–1743. doi: 10.1021/bi00430a047. [DOI] [PubMed] [Google Scholar]
  4. Bates P., Young J. A., Varmus H. E. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell. 1993 Sep 24;74(6):1043–1051. doi: 10.1016/0092-8674(93)90726-7. [DOI] [PubMed] [Google Scholar]
  5. Battaglia C., Aumailley M., Mann K., Mayer U., Timpl R. Structural basis of beta 1 integrin-mediated cell adhesion to a large heparan sulfate proteoglycan from basement membranes. Eur J Cell Biol. 1993 Jun;61(1):92–99. [PubMed] [Google Scholar]
  6. Battaglia C., Mayer U., Aumailley M., Timpl R. Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core. Eur J Biochem. 1992 Sep 1;208(2):359–366. doi: 10.1111/j.1432-1033.1992.tb17195.x. [DOI] [PubMed] [Google Scholar]
  7. Berenson G. S., Ruiz H., Dalferes E. R., Jr, Dugan F. A., Radhakrishnamurthy B. Acid mucopolysaccharide changes in diabetic kidneys. Diabetes. 1970 Mar;19(3):161–170. doi: 10.2337/diab.19.3.161. [DOI] [PubMed] [Google Scholar]
  8. Bernfield M. R., Banerjee S. D., Cohn R. H. Dependence of salivary epithelial morphology and branching morphogenesis upon acid mucopolysaccharide-protein (proteoglycan) at the epithelial surface. J Cell Biol. 1972 Mar;52(3):674–689. doi: 10.1083/jcb.52.3.674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bernfield M., Kokenyesi R., Kato M., Hinkes M. T., Spring J., Gallo R. L., Lose E. J. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol. 1992;8:365–393. doi: 10.1146/annurev.cb.08.110192.002053. [DOI] [PubMed] [Google Scholar]
  10. Bird A. P. CpG-rich islands and the function of DNA methylation. Nature. 1986 May 15;321(6067):209–213. doi: 10.1038/321209a0. [DOI] [PubMed] [Google Scholar]
  11. Bruns G. A., Sherman S. L. Report of the committee on the genetic constitution of chromosome 1. Cytogenet Cell Genet. 1989;51(1-4):67–90. doi: 10.1159/000132781. [DOI] [PubMed] [Google Scholar]
  12. Burgeson R. E., Chiquet M., Deutzmann R., Ekblom P., Engel J., Kleinman H., Martin G. R., Meneguzzi G., Paulsson M., Sanes J. A new nomenclature for the laminins. Matrix Biol. 1994 Apr;14(3):209–211. doi: 10.1016/0945-053x(94)90184-8. [DOI] [PubMed] [Google Scholar]
  13. Carey D. J., Evans D. M., Stahl R. C., Asundi V. K., Conner K. J., Garbes P., Cizmeci-Smith G. Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan. J Cell Biol. 1992 Apr;117(1):191–201. doi: 10.1083/jcb.117.1.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Carson D. D., Tang J. P., Julian J. Heparan sulfate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence. Dev Biol. 1993 Jan;155(1):97–106. doi: 10.1006/dbio.1993.1010. [DOI] [PubMed] [Google Scholar]
  15. Chakravarti S., Phillips S. L., Hassell J. R. Assignment of the perlecan (heparan sulfate proteoglycan) gene to mouse chromosome 4. Mamm Genome. 1991;1(4):270–272. doi: 10.1007/BF00352338. [DOI] [PubMed] [Google Scholar]
  16. Clément B., Segui-Real B., Hassell J. R., Martin G. R., Yamada Y. Identification of a cell surface-binding protein for the core protein of the basement membrane proteoglycan. J Biol Chem. 1989 Jul 25;264(21):12467–12471. [PubMed] [Google Scholar]
  17. Cohen I. R., Grässel S., Murdoch A. D., Iozzo R. V. Structural characterization of the complete human perlecan gene and its promoter. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10404–10408. doi: 10.1073/pnas.90.21.10404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Cohen M. P., Surma M. L. [(35)S]sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes. J Lab Clin Med. 1981 Nov;98(5):715–722. [PubMed] [Google Scholar]
  19. Colwell G., Li B., Forrest D., Brackenbury R. Conserved regulatory elements in the promoter region of the N-CAM gene. Genomics. 1992 Dec;14(4):875–882. doi: 10.1016/s0888-7543(05)80108-9. [DOI] [PubMed] [Google Scholar]
  20. Couchman J. R. Heterogeneous distribution of a basement membrane heparan sulfate proteoglycan in rat tissues. J Cell Biol. 1987 Oct;105(4):1901–1916. doi: 10.1083/jcb.105.4.1901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Couchman J. R., Ljubimov A. V. Mammalian tissue distribution of a large heparan sulfate proteoglycan detected by monoclonal antibodies. Matrix. 1989 Aug;9(4):311–321. doi: 10.1016/s0934-8832(89)80007-1. [DOI] [PubMed] [Google Scholar]
  22. Cunningham B. A., Hemperly J. J., Murray B. A., Prediger E. A., Brackenbury R., Edelman G. M. Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science. 1987 May 15;236(4803):799–806. doi: 10.1126/science.3576199. [DOI] [PubMed] [Google Scholar]
  23. Danielson K. G., Martinez-Hernandez A., Hassell J. R., Iozzo R. V. Establishment of a cell line from the EHS tumor: biosynthesis of basement membrane constituents and characterization of a hybrid proteoglycan containing heparan and chondroitin sulfate chains. Matrix. 1992 Feb;12(1):22–35. doi: 10.1016/s0934-8832(11)80101-0. [DOI] [PubMed] [Google Scholar]
  24. David G., Lories V., Decock B., Marynen P., Cassiman J. J., Van den Berghe H. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J Cell Biol. 1990 Dec;111(6 Pt 2):3165–3176. doi: 10.1083/jcb.111.6.3165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. David G., van der Schueren B., Marynen P., Cassiman J. J., van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol. 1992 Aug;118(4):961–969. doi: 10.1083/jcb.118.4.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Dodge G. R., Kovalszky I., Chu M. L., Hassell J. R., McBride O. W., Yi H. F., Iozzo R. V. Heparan sulfate proteoglycan of human colon: partial molecular cloning, cellular expression, and mapping of the gene (HSPG2) to the short arm of human chromosome 1. Genomics. 1991 Jul;10(3):673–680. doi: 10.1016/0888-7543(91)90451-j. [DOI] [PubMed] [Google Scholar]
  27. Dodge G. R., Kovalszky I., Hassell J. R., Iozzo R. V. Transforming growth factor beta alters the expression of heparan sulfate proteoglycan in human colon carcinoma cells. J Biol Chem. 1990 Oct 15;265(29):18023–18029. [PubMed] [Google Scholar]
  28. Dracopoli N. C., Harnett P., Bale S. J., Stanger B. Z., Tucker M. A., Housman D. E., Kefford R. F. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4614–4618. doi: 10.1073/pnas.86.12.4614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Dziadek M., Fujiwara S., Paulsson M., Timpl R. Immunological characterization of basement membrane types of heparan sulfate proteoglycan. EMBO J. 1985 Apr;4(4):905–912. doi: 10.1002/j.1460-2075.1985.tb03717.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Esko J. D. Genetic analysis of proteoglycan structure, function and metabolism. Curr Opin Cell Biol. 1991 Oct;3(5):805–816. doi: 10.1016/0955-0674(91)90054-3. [DOI] [PubMed] [Google Scholar]
  31. Esko J. D., Rostand K. S., Weinke J. L. Tumor formation dependent on proteoglycan biosynthesis. Science. 1988 Aug 26;241(4869):1092–1096. doi: 10.1126/science.3137658. [DOI] [PubMed] [Google Scholar]
  32. Folkman J., Klagsbrun M., Sasse J., Wadzinski M., Ingber D., Vlodavsky I. A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol. 1988 Feb;130(2):393–400. [PMC free article] [PubMed] [Google Scholar]
  33. Folkman J., Shing Y. Angiogenesis. J Biol Chem. 1992 Jun 5;267(16):10931–10934. [PubMed] [Google Scholar]
  34. Fong C. T., Dracopoli N. C., White P. S., Merrill P. T., Griffith R. C., Housman D. E., Brodeur G. M. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci U S A. 1989 May;86(10):3753–3757. doi: 10.1073/pnas.86.10.3753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Gallagher J. T. The extended family of proteoglycans: social residents of the pericellular zone. Curr Opin Cell Biol. 1989 Dec;1(6):1201–1218. doi: 10.1016/s0955-0674(89)80072-9. [DOI] [PubMed] [Google Scholar]
  36. Genuardi M., Tsihira H., Anderson D. E., Saunders G. F. Distal deletion of chromosome Ip in ductal carcinoma of the breast. Am J Hum Genet. 1989 Jul;45(1):73–82. [PMC free article] [PubMed] [Google Scholar]
  37. Gilbert W. Genes-in-pieces revisited. Science. 1985 May 17;228(4701):823–824. doi: 10.1126/science.4001923. [DOI] [PubMed] [Google Scholar]
  38. Gilchrist E. J., Moerman D. G. Mutations in the sup-38 gene of Caenorhabditis elegans suppress muscle-attachment defects in unc-52 mutants. Genetics. 1992 Oct;132(2):431–442. doi: 10.1093/genetics/132.2.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Gordon J. R., Bernfield M. R. The basal lamina of the postnatal mammary epithelium contains glycosaminoglycans in a precise ultrastructural organization. Dev Biol. 1980 Jan;74(1):118–135. doi: 10.1016/0012-1606(80)90056-1. [DOI] [PubMed] [Google Scholar]
  40. Grant D. S., Leblond C. P. Immunogold quantitation of laminin, type IV collagen, and heparan sulfate proteoglycan in a variety of basement membranes. J Histochem Cytochem. 1988 Mar;36(3):271–283. doi: 10.1177/36.3.2963856. [DOI] [PubMed] [Google Scholar]
  41. Grant D. S., Leblond C. P., Kleinman H. K., Inoue S., Hassell J. R. The incubation of laminin, collagen IV, and heparan sulfate proteoglycan at 35 degrees C yields basement membrane-like structures. J Cell Biol. 1989 Apr;108(4):1567–1574. doi: 10.1083/jcb.108.4.1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Greene M. H., Goldin L. R., Clark W. H., Jr, Lovrien E., Kraemer K. H., Tucker M. A., Elder D. E., Fraser M. C., Rowe S. Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci U S A. 1983 Oct;80(19):6071–6075. doi: 10.1073/pnas.80.19.6071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Haaparanta T., Uitto J., Ruoslahti E., Engvall E. Molecular cloning of the cDNA encoding human laminin A chain. Matrix. 1991 Jun;11(3):151–160. doi: 10.1016/s0934-8832(11)80153-8. [DOI] [PubMed] [Google Scholar]
  44. Hagen S. G., Michael A. F., Butkowski R. J. Immunochemical and biochemical evidence for distinct basement membrane heparan sulfate proteoglycans. J Biol Chem. 1993 Apr 5;268(10):7261–7269. [PubMed] [Google Scholar]
  45. Hassell J. R., Leyshon W. C., Ledbetter S. R., Tyree B., Suzuki S., Kato M., Kimata K., Kleinman H. K. Isolation of two forms of basement membrane proteoglycans. J Biol Chem. 1985 Jul 5;260(13):8098–8105. [PubMed] [Google Scholar]
  46. Hassell J. R., Robey P. G., Barrach H. J., Wilczek J., Rennard S. I., Martin G. R. Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4494–4498. doi: 10.1073/pnas.77.8.4494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Hassell J. R., Schrecengost P. K., Rada J. A., SundarRaj N., Sossi G., Thoft R. A. Biosynthesis of stromal matrix proteoglycans and basement membrane components by human corneal fibroblasts. Invest Ophthalmol Vis Sci. 1992 Mar;33(3):547–557. [PubMed] [Google Scholar]
  48. Hayashi K., Madri J. A., Yurchenco P. D. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan. J Cell Biol. 1992 Nov;119(4):945–959. doi: 10.1083/jcb.119.4.945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Heremans A., Cassiman J. J., Van den Berghe H., David G. Heparan sulfate proteoglycan from the extracellular matrix of human lung fibroblasts. Isolation, purification, and core protein characterization. J Biol Chem. 1988 Apr 5;263(10):4731–4739. [PubMed] [Google Scholar]
  50. Heremans A., De Cock B., Cassiman J. J., Van den Berghe H., David G. The core protein of the matrix-associated heparan sulfate proteoglycan binds to fibronectin. J Biol Chem. 1990 May 25;265(15):8716–8724. [PubMed] [Google Scholar]
  51. Heremans A., van der Schueren B., de Cock B., Paulsson M., Cassiman J. J., van den Berghe H., David G. Matrix-associated heparan sulfate proteoglycan: core protein-specific monoclonal antibodies decorate the pericellular matrix of connective tissue cells and the stromal side of basement membranes. J Cell Biol. 1989 Dec;109(6 Pt 1):3199–3211. doi: 10.1083/jcb.109.6.3199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Horiguchi Y., Fine J. D., Couchman J. R. Human skin basement membrane-associated heparan sulphate proteoglycan: distinctive differences in ultrastructural localization as a function of developmental age. Br J Dermatol. 1991 May;124(5):410–414. doi: 10.1111/j.1365-2133.1991.tb00617.x. [DOI] [PubMed] [Google Scholar]
  53. Hunter D. D., Porter B. E., Bulock J. W., Adams S. P., Merlie J. P., Sanes J. R. Primary sequence of a motor neuron-selective adhesive site in the synaptic basal lamina protein S-laminin. Cell. 1989 Dec 1;59(5):905–913. doi: 10.1016/0092-8674(89)90613-2. [DOI] [PubMed] [Google Scholar]
  54. Imamura T., Tokita Y., Mitsui Y. Contact with basement membrane heparan sulfate enhances the growth of transformed vascular endothelial cells, but suppresses normal cells. Cell Struct Funct. 1991 Jun;16(3):225–230. doi: 10.1247/csf.16.225. [DOI] [PubMed] [Google Scholar]
  55. Inoue S., Grant D., Leblond C. P. Heparan sulfate proteoglycan is present in basement membrane as a double-tracked structure. J Histochem Cytochem. 1989 May;37(5):597–602. doi: 10.1177/37.5.2522961. [DOI] [PubMed] [Google Scholar]
  56. Iozzo R. V. Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface. J Cell Biol. 1984 Aug;99(2):403–417. doi: 10.1083/jcb.99.2.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Iozzo R. V. Cell surface heparan sulfate proteoglycan and the neoplastic phenotype. J Cell Biochem. 1988 May;37(1):61–78. doi: 10.1002/jcb.240370107. [DOI] [PubMed] [Google Scholar]
  58. Iozzo R. V., Hassell J. R. Identification of the precursor protein for the heparan sulfate proteoglycan of human colon carcinoma cells and its post-translational modifications. Arch Biochem Biophys. 1989 Feb 15;269(1):239–249. doi: 10.1016/0003-9861(89)90105-7. [DOI] [PubMed] [Google Scholar]
  59. Iozzo R. V., Kovalszky I., Hacobian N., Schick P. K., Ellingson J. S., Dodge G. R. Fatty acylation of heparan sulfate proteoglycan from human colon carcinoma cells. J Biol Chem. 1990 Nov 15;265(32):19980–19989. [PubMed] [Google Scholar]
  60. Isemura M., Sato N., Yamaguchi Y., Aikawa J., Munakata H., Hayashi N., Yosizawa Z., Nakamura T., Kubota A., Arakawa M. Isolation and characterization of fibronectin-binding proteoglycan carrying both heparan sulfate and dermatan sulfate chains from human placenta. J Biol Chem. 1987 Jun 25;262(18):8926–8933. [PubMed] [Google Scholar]
  61. Jalkanen M., Rapraeger A., Bernfield M. Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins. J Cell Biol. 1988 Mar;106(3):953–962. doi: 10.1083/jcb.106.3.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Kallunki P., Eddy R. L., Byers M. G., Kestilä M., Shows T. B., Tryggvason K. Cloning of human heparan sulfate proteoglycan core protein, assignment of the gene (HSPG2) to 1p36.1----p35 and identification of a BamHI restriction fragment length polymorphism. Genomics. 1991 Oct;11(2):389–396. doi: 10.1016/0888-7543(91)90147-7. [DOI] [PubMed] [Google Scholar]
  63. Kallunki P., Tryggvason K. Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Cell Biol. 1992 Jan;116(2):559–571. doi: 10.1083/jcb.116.2.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Kallunki T., Ikonen J., Chow L. T., Kallunki P., Tryggvason K. Structure of the human laminin B2 chain gene reveals extensive divergence from the laminin B1 chain gene. J Biol Chem. 1991 Jan 5;266(1):221–228. [PubMed] [Google Scholar]
  65. Kanwar Y. S., Farquhar M. G. Presence of heparan sulfate in the glomerular basement membrane. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1303–1307. doi: 10.1073/pnas.76.3.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Kanwar Y. S., Linker A., Farquhar M. G. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol. 1980 Aug;86(2):688–693. doi: 10.1083/jcb.86.2.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Kanwar Y. S., Rosenzweig L. J., Linker A., Jakubowski M. L. Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2272–2275. doi: 10.1073/pnas.80.8.2272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Kato M., Koike Y., Suzuki S., Kimata K. Basement membrane proteoglycan in various tissues: characterization using monoclonal antibodies to the Engelbreth-Holm-Swarm mouse tumor low density heparan sulfate proteoglycan. J Cell Biol. 1988 Jun;106(6):2203–2210. doi: 10.1083/jcb.106.6.2203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Kjellén L., Bielefeld D., Hook M. Reduced sulfation of liver heparan sulfate in experimentally diabetic rats. Diabetes. 1983 Apr;32(4):337–342. doi: 10.2337/diab.32.4.337. [DOI] [PubMed] [Google Scholar]
  70. Klein D. J., Brown D. M., Oegema T. R., Brenchley P. E., Anderson J. C., Dickinson M. A., Horigan E. A., Hassell J. R. Glomerular basement membrane proteoglycans are derived from a large precursor. J Cell Biol. 1988 Mar;106(3):963–970. doi: 10.1083/jcb.106.3.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Klein D. J., Oegema T. R., Jr, Brown D. M. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats. Diabetes. 1989 Jan;38(1):130–139. doi: 10.2337/diab.38.1.130. [DOI] [PubMed] [Google Scholar]
  72. Kleinman H. K., McGarvey M. L., Hassell J. R., Star V. L., Cannon F. B., Laurie G. W., Martin G. R. Basement membrane complexes with biological activity. Biochemistry. 1986 Jan 28;25(2):312–318. doi: 10.1021/bi00350a005. [DOI] [PubMed] [Google Scholar]
  73. Kleinman H. K., McGarvey M. L., Liotta L. A., Robey P. G., Tryggvason K., Martin G. R. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry. 1982 Nov 23;21(24):6188–6193. doi: 10.1021/bi00267a025. [DOI] [PubMed] [Google Scholar]
  74. Laurie G. W., Leblond C. P., Inoue S., Martin G. R., Chung A. Fine structure of the glomerular basement membrane and immunolocalization of five basement membrane components to the lamina densa (basal lamina) and its extensions in both glomeruli and tubules of the rat kidney. Am J Anat. 1984 Apr;169(4):463–481. doi: 10.1002/aja.1001690408. [DOI] [PubMed] [Google Scholar]
  75. Ledbetter S. R., Tyree B., Hassell J. R., Horigan E. A. Identification of the precursor protein to basement membrane heparan sulfate proteoglycans. J Biol Chem. 1985 Jul 5;260(13):8106–8113. [PubMed] [Google Scholar]
  76. Ledbetter S., Copeland E. J., Noonan D., Vogeli G., Hassell J. R. Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes. 1990 Feb;39(2):196–203. doi: 10.2337/diab.39.2.196. [DOI] [PubMed] [Google Scholar]
  77. Leister I., Weith A., Brüderlein S., Cziepluch C., Kangwanpong D., Schlag P., Schwab M. Human colorectal cancer: high frequency of deletions at chromosome 1p35. Cancer Res. 1990 Nov 15;50(22):7232–7235. [PubMed] [Google Scholar]
  78. Ljubimov A. V., Bartek J., Couchman J. R., Kapuller L. L., Veselov V. V., Kovarik J., Perevoshchikov A. G., Krutovskikh V. A. Distribution of individual components of basement membrane in human colon polyps and adenocarcinomas as revealed by monoclonal antibodies. Int J Cancer. 1992 Feb 20;50(4):562–566. doi: 10.1002/ijc.2910500412. [DOI] [PubMed] [Google Scholar]
  79. Lortat-Jacob H., Kleinman H. K., Grimaud J. A. High-affinity binding of interferon-gamma to a basement membrane complex (matrigel). J Clin Invest. 1991 Mar;87(3):878–883. doi: 10.1172/JCI115093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. López-Casillas F., Cheifetz S., Doody J., Andres J. L., Lane W. S., Massagué J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell. 1991 Nov 15;67(4):785–795. doi: 10.1016/0092-8674(91)90073-8. [DOI] [PubMed] [Google Scholar]
  81. Mali M., Jaakkola P., Arvilommi A. M., Jalkanen M. Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans. J Biol Chem. 1990 Apr 25;265(12):6884–6889. [PubMed] [Google Scholar]
  82. Marchetti D., Menter D., Jin L., Nakajima M., Nicolson G. L. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int J Cancer. 1993 Oct 21;55(4):692–699. doi: 10.1002/ijc.2910550430. [DOI] [PubMed] [Google Scholar]
  83. Mathew C. G., Smith B. A., Thorpe K., Wong Z., Royle N. J., Jeffreys A. J., Ponder B. A. Deletion of genes on chromosome 1 in endocrine neoplasia. Nature. 1987 Aug 6;328(6130):524–526. doi: 10.1038/328524a0. [DOI] [PubMed] [Google Scholar]
  84. Mitchell P. J., Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 1989 Jul 28;245(4916):371–378. doi: 10.1126/science.2667136. [DOI] [PubMed] [Google Scholar]
  85. Moscatelli D. Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells. J Cell Biol. 1988 Aug;107(2):753–759. doi: 10.1083/jcb.107.2.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Murdoch A. D., Dodge G. R., Cohen I., Tuan R. S., Iozzo R. V. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Biol Chem. 1992 Apr 25;267(12):8544–8557. [PubMed] [Google Scholar]
  87. Murdoch A. D., Liu B., Schwarting R., Tuan R. S., Iozzo R. V. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J Histochem Cytochem. 1994 Feb;42(2):239–249. doi: 10.1177/42.2.7507142. [DOI] [PubMed] [Google Scholar]
  88. Nakajima M., Irimura T., Di Ferrante D., Di Ferrante N., Nicolson G. L. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science. 1983 May 6;220(4597):611–613. doi: 10.1126/science.6220468. [DOI] [PubMed] [Google Scholar]
  89. Nakajima M., Irimura T., Di Ferrante N., Nicolson G. L. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem. 1984 Feb 25;259(4):2283–2290. [PubMed] [Google Scholar]
  90. Nakanishi H., Oguri K., Yoshida K., Itano N., Takenaga K., Kazama T., Yoshida A., Okayama M. Structural differences between heparan sulphates of proteoglycan involved in the formation of basement membranes in vivo by Lewis-lung-carcinoma-derived cloned cells with different metastatic potentials. Biochem J. 1992 Nov 15;288(Pt 1):215–224. doi: 10.1042/bj2880215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Nakanishi H., Okayama M., Oguri K., Hayashi K., Tateno H., Hosoda S. Close association between tumour cells and vascular basement membrane in gastric cancers with liver metastasis. An immunohistochemical and electron microscopic study with special attention to extracellular matrices. Virchows Arch A Pathol Anat Histopathol. 1991;418(6):531–538. doi: 10.1007/BF01606504. [DOI] [PubMed] [Google Scholar]
  92. Nakanishi H., Takenaga K., Oguri K., Yoshida A., Okayama M. Morphological characteristics of tumours formed by Lewis lung carcinoma-derived cloned cell lines with different metastatic potentials: structural differences in their basement membranes formed in vivo. Virchows Arch A Pathol Anat Histopathol. 1992;420(2):163–170. doi: 10.1007/BF02358808. [DOI] [PubMed] [Google Scholar]
  93. Noonan D. M., Fulle A., Valente P., Cai S., Horigan E., Sasaki M., Yamada Y., Hassell J. R. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem. 1991 Dec 5;266(34):22939–22947. [PubMed] [Google Scholar]
  94. Noonan D. M., Hassell J. R. Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms. Kidney Int. 1993 Jan;43(1):53–60. doi: 10.1038/ki.1993.10. [DOI] [PubMed] [Google Scholar]
  95. Noonan D. M., Horigan E. A., Ledbetter S. R., Vogeli G., Sasaki M., Yamada Y., Hassell J. R. Identification of cDNA clones encoding different domains of the basement membrane heparan sulfate proteoglycan. J Biol Chem. 1988 Nov 5;263(31):16379–16387. [PubMed] [Google Scholar]
  96. Ohtani H., Nakamura S., Watanabe Y., Mizoi T., Saku T., Nagura H. Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest. 1993 May;68(5):520–527. [PubMed] [Google Scholar]
  97. Olgemöller B., Schleicher E. D., Schwaabe S., Guretzki H. J., Gerbitz K. D. High concentrations of low density lipoprotein decrease basement membrane-associated heparan sulfate proteoglycan in cultured endothelial cells. FEBS Lett. 1990 May 7;264(1):37–39. doi: 10.1016/0014-5793(90)80758-b. [DOI] [PubMed] [Google Scholar]
  98. Ornitz D. M., Yayon A., Flanagan J. G., Svahn C. M., Levi E., Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol. 1992 Jan;12(1):240–247. doi: 10.1128/mcb.12.1.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Parthasarathy N., Spiro R. G. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes. 1982 Aug;31(8 Pt 1):738–741. doi: 10.2337/diab.31.8.738. [DOI] [PubMed] [Google Scholar]
  100. Paulsson M., Yurchenco P. D., Ruben G. C., Engel J., Timpl R. Structure of low density heparan sulfate proteoglycan isolated from a mouse tumor basement membrane. J Mol Biol. 1987 Sep 20;197(2):297–313. doi: 10.1016/0022-2836(87)90125-2. [DOI] [PubMed] [Google Scholar]
  101. Paulus W., Grothe C., Sensenbrenner M., Janet T., Baur I., Graf M., Roggendorf W. Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors. Acta Neuropathol. 1990;79(4):418–423. doi: 10.1007/BF00308718. [DOI] [PubMed] [Google Scholar]
  102. Pihlajaniemi T., Myllylä R., Kivirikko K. I., Tryggvason K. Effects of streptozotocin diabetes, glucose, and insulin on the metabolism of type IV collagen and proteoglycan in murine basement membrane-forming EHS tumor tissue. J Biol Chem. 1982 Dec 25;257(24):14914–14920. [PubMed] [Google Scholar]
  103. Raychowdhury R., Niles J. L., McCluskey R. T., Smith J. A. Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science. 1989 Jun 9;244(4909):1163–1165. doi: 10.1126/science.2786251. [DOI] [PubMed] [Google Scholar]
  104. Reinhardt D., Mann K., Nischt R., Fox J. W., Chu M. L., Krieg T., Timpl R. Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc. J Biol Chem. 1993 May 25;268(15):10881–10887. [PubMed] [Google Scholar]
  105. Rescan P. Y., Loréal O., Hassell J. R., Yamada Y., Guillouzo A., Clément B. Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture. Am J Pathol. 1993 Jan;142(1):199–208. [PMC free article] [PubMed] [Google Scholar]
  106. Rogalski T. M., Williams B. D., Mullen G. P., Moerman D. G. Products of the unc-52 gene in Caenorhabditis elegans are homologous to the core protein of the mammalian basement membrane heparan sulfate proteoglycan. Genes Dev. 1993 Aug;7(8):1471–1484. doi: 10.1101/gad.7.8.1471. [DOI] [PubMed] [Google Scholar]
  107. Rohrbach D. H., Hassell J. R., Kleinman H. K., Martin G. R. Alterations in the basement membrane (heparan sulfate) proteoglycan in diabetic mice. Diabetes. 1982 Feb;31(2):185–188. doi: 10.2337/diab.31.2.185. [DOI] [PubMed] [Google Scholar]
  108. Rohrbach D. H., Wagner C. W., Star V. L., Martin G. R., Brown K. S., Yoon J. W. Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin-induced diabetic mice. J Biol Chem. 1983 Oct 10;258(19):11672–11677. [PubMed] [Google Scholar]
  109. Ruoslahti E., Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 1991 Mar 8;64(5):867–869. doi: 10.1016/0092-8674(91)90308-l. [DOI] [PubMed] [Google Scholar]
  110. Rupp F., Payan D. G., Magill-Solc C., Cowan D. M., Scheller R. H. Structure and expression of a rat agrin. Neuron. 1991 May;6(5):811–823. doi: 10.1016/0896-6273(91)90177-2. [DOI] [PubMed] [Google Scholar]
  111. Rutishauser U., Acheson A., Hall A. K., Mann D. M., Sunshine J. The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science. 1988 Apr 1;240(4848):53–57. doi: 10.1126/science.3281256. [DOI] [PubMed] [Google Scholar]
  112. Saksela O., Moscatelli D., Sommer A., Rifkin D. B. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol. 1988 Aug;107(2):743–751. doi: 10.1083/jcb.107.2.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Saksela O., Rifkin D. B. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol. 1990 Mar;110(3):767–775. doi: 10.1083/jcb.110.3.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Saku T., Furthmayr H. Characterization of the major heparan sulfate proteoglycan secreted by bovine aortic endothelial cells in culture. Homology to the large molecular weight molecule of basement membranes. J Biol Chem. 1989 Feb 25;264(6):3514–3523. [PubMed] [Google Scholar]
  115. Sasaki M., Kleinman H. K., Huber H., Deutzmann R., Yamada Y. Laminin, a multidomain protein. The A chain has a unique globular domain and homology with the basement membrane proteoglycan and the laminin B chains. J Biol Chem. 1988 Nov 15;263(32):16536–16544. [PubMed] [Google Scholar]
  116. Sasisekharan R., Moses M. A., Nugent M. A., Cooney C. L., Langer R. Heparinase inhibits neovascularization. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1524–1528. doi: 10.1073/pnas.91.4.1524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Simon-Assmann P., Bouziges F., Vigny M., Kedinger M. Origin and deposition of basement membrane heparan sulfate proteoglycan in the developing intestine. J Cell Biol. 1989 Oct;109(4 Pt 1):1837–1848. doi: 10.1083/jcb.109.4.1837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Skubitz A. P., Letourneau P. C., Wayner E., Furcht L. T. Synthetic peptides from the carboxy-terminal globular domain of the A chain of laminin: their ability to promote cell adhesion and neurite outgrowth, and interact with heparin and the beta 1 integrin subunit. J Cell Biol. 1991 Nov;115(4):1137–1148. doi: 10.1083/jcb.115.4.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Stanley K. K. The molecular mechanism of complement C9 insertion and polymerisation in biological membranes. Curr Top Microbiol Immunol. 1989;140:49–65. doi: 10.1007/978-3-642-73911-8_5. [DOI] [PubMed] [Google Scholar]
  120. Stow J. L., Sawada H., Farquhar M. G. Basement membrane heparan sulfate proteoglycans are concentrated in the laminae rarae and in podocytes of the rat renal glomerulus. Proc Natl Acad Sci U S A. 1985 May;82(10):3296–3300. doi: 10.1073/pnas.82.10.3296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Strickland D. K., Ashcom J. D., Williams S., Burgess W. H., Migliorini M., Argraves W. S. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J Biol Chem. 1990 Oct 15;265(29):17401–17404. [PubMed] [Google Scholar]
  122. Südhof T. C., Goldstein J. L., Brown M. S., Russell D. W. The LDL receptor gene: a mosaic of exons shared with different proteins. Science. 1985 May 17;228(4701):815–822. doi: 10.1126/science.2988123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Timar J., Ladanyi A., Lapis K., Moczar M. Differential expression of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential. Am J Pathol. 1992 Aug;141(2):467–474. [PMC free article] [PubMed] [Google Scholar]
  124. Timpl R. Proteoglycans of basement membranes. Experientia. 1993 May 15;49(5):417–428. doi: 10.1007/BF01923586. [DOI] [PubMed] [Google Scholar]
  125. Traut T. W. Do exons code for structural or functional units in proteins? Proc Natl Acad Sci U S A. 1988 May;85(9):2944–2948. doi: 10.1073/pnas.85.9.2944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Turnbull J. E., Fernig D. G., Ke Y., Wilkinson M. C., Gallagher J. T. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J Biol Chem. 1992 May 25;267(15):10337–10341. [PubMed] [Google Scholar]
  127. Turnbull J. E., Gallagher J. T. Heparan sulphate: functional role as a modulator of fibroblast growth factor activity. Biochem Soc Trans. 1993 May;21(2):477–482. doi: 10.1042/bst0210477. [DOI] [PubMed] [Google Scholar]
  128. Ushkaryov Y. A., Petrenko A. G., Geppert M., Südhof T. C. Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. Science. 1992 Jul 3;257(5066):50–56. doi: 10.1126/science.1621094. [DOI] [PubMed] [Google Scholar]
  129. Ushkaryov Y. A., Südhof T. C. Neurexin III alpha: extensive alternative splicing generates membrane-bound and soluble forms. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6410–6414. doi: 10.1073/pnas.90.14.6410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Vigny M., Ollier-Hartmann M. P., Lavigne M., Fayein N., Jeanny J. C., Laurent M., Courtois Y. Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparan sulfate proteoglycan of the EHS tumor. J Cell Physiol. 1988 Nov;137(2):321–328. doi: 10.1002/jcp.1041370216. [DOI] [PubMed] [Google Scholar]
  131. Vlodavsky I., Bar-Shavit R., Ishai-Michaeli R., Bashkin P., Fuks Z. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci. 1991 Jul;16(7):268–271. doi: 10.1016/0968-0004(91)90102-2. [DOI] [PubMed] [Google Scholar]
  132. Vuolteenaho R., Chow L. T., Tryggvason K. Structure of the human laminin B1 chain gene. J Biol Chem. 1990 Sep 15;265(26):15611–15616. [PubMed] [Google Scholar]
  133. Weith A., Martinsson T., Cziepluch C., Brüderlein S., Amler L. C., Berthold F., Schwab M. Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosomes Cancer. 1989 Nov;1(2):159–166. doi: 10.1002/gcc.2870010209. [DOI] [PubMed] [Google Scholar]
  134. Wight T. N., Kinsella M. G., Qwarnström E. E. The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol. 1992 Oct;4(5):793–801. doi: 10.1016/0955-0674(92)90102-i. [DOI] [PubMed] [Google Scholar]
  135. Williams K. J., Fless G. M., Petrie K. A., Snyder M. L., Brocia R. W., Swenson T. L. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J Biol Chem. 1992 Jul 5;267(19):13284–13292. [PubMed] [Google Scholar]
  136. Wintle R. F., Kisilevsky R., Noonan D., Duncan A. M. In situ hybridization to human chromosome 1 of a cDNA probe for the gene encoding the basement membrane heparan sulfate proteoglycan (HSPG). Cytogenet Cell Genet. 1990;54(1-2):60–61. doi: 10.1159/000132956. [DOI] [PubMed] [Google Scholar]
  137. Yayon A., Klagsbrun M., Esko J. D., Leder P., Ornitz D. M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 1991 Feb 22;64(4):841–848. doi: 10.1016/0092-8674(91)90512-w. [DOI] [PubMed] [Google Scholar]
  138. Yochem J., Greenwald I. A gene for a low density lipoprotein receptor-related protein in the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4572–4576. doi: 10.1073/pnas.90.10.4572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Yurchenco P. D., Cheng Y. S., Ruben G. C. Self-assembly of a high molecular weight basement membrane heparan sulfate proteoglycan into dimers and oligomers. J Biol Chem. 1987 Dec 25;262(36):17668–17676. [PubMed] [Google Scholar]
  140. Yurchenco P. D., Schittny J. C. Molecular architecture of basement membranes. FASEB J. 1990 Apr 1;4(6):1577–1590. doi: 10.1096/fasebj.4.6.2180767. [DOI] [PubMed] [Google Scholar]